FDA warns Glens Falls, NY-based Medline Industries about Quality System violations in its manufacturing and assembly of cardiovascular procedure kits.
FDA solicits applications for its new READI-Home innovation challenge to use medical technology in the home to reduce or prevent hospital readmissions...
Healthcare advocacy organizations call on key House lawmakers to hold hearings and advance bipartisan legislation aimed at lowering prescription drug ...
FDA agrees to hear an Outlook Therapeutics formal dispute resolution request regarding the agencys prior rejection of eye disease therapy Lytenava (be...
A federal judge declines to immediately restrict access to the abortion pill mifepristone, instead pausing a high-profile lawsuit brought by Louisiana...
Three stakeholders express support for FDAs LEADER 3D rare disease educational materials and suggest ways to improve them.
Amgen reports positive topline results from a Phase 3 trial evaluating a subcutaneous version of its thyroid eye disease drug Tepezza (teprotumumab-tr...
ImmunityBio says it has responded to FDAs recent Warning Letter on the companys alleged misleading promotional claims about its cancer therapy Anktiva...
